Mechancial properties of bat wing membrane skin

The skin of the bat wing in functionally unique among mammals: it serves as a major locomotor organ in addition to its protective and regulatory functions. We used tensile testing to investigate the mechanical capabilities of wing membrane skin, and compared stiffness, strength, load at failure, and energy absorption among specific wing regions and among a variety of bat taxa. We related these characteristics to the highly architectural fibrous supporting network of the wing membrane. We found that all material properties showed a strong anisotropy. In particular, wing membrane skin shows maximum stiffness and stregth parallel to the wing skeleton, and greatest extensibility parallel to the wing's trailing edge. We also found significant variation among wing regions. The uropatagium (tail membrane) supported the greatest load at failure, and the plagiopatagium (proximal wing membrane between laterl body wall and hand skeleton) is the weakest and most extensible part of the wing. We believe that the increased load bearing ability of the uropatagium relats to its key role in capture of insect prey, and that the great extensibility of the plagiopatagium promotes development of camber near the wing's centre of lift. In interspecific comparisons, energy absorpion and load to failure were greatest in Artibeus jamaicensis , the largest bat in our sample and the species with the highest wing loading, suggesting that wing loading may play a role in dictating the fuctional design of wing membranes.     

Dextran production by Leuconostoc mesenteroides in the presence of a dextranase producing yeast, Lipomyces starkeyi

Summary A new process for the production of small size dextran is developed in which dextran is produced by cultures of Leuconostoc mesenteroides in the presence of a partially constitutive mutant of Lipomyces starkeyi producing dextranase. Mixed cultures were examined by scanning electron microscopy with ruthenium to show the effects of the mixed culture on low molecular weight dextran (M.W. of 5,000 – 100,000) formation. The presence of the size variation in dextran was confirmed by gel permeation chromatography.     

Production of cyclodextrins using moderately heat-treated cornstarch

Cyclodextrins are very useful compounds for the food, cosmetic, pharmaceutic, and plastic industries. We developed a process for the production of cyclodextrins from moderately heat-treated cornstarch. This method had many merits. First, the cyclodextrins were not degraded by cyclodextrin glucanotransferase, because low molecular weight maltodextrins were hardly produced. Second, it was possible to remove the residual cornstarch by a simple method such as filtration or centrifugation. Third, the amount of cyclodextrin glucanotransferase used for cyclodextrin production was less than that using the traditional method. Fourth, the pretreating method was simple. And fifth, the residual starch could be used as substrate for the production of other compounds. Cyclodextrins were produced at optimum conditions: heating temperature was 65°C; heating time was 1 h; concentration of substrate was 7.5%; amount of enzyme loaded was 48 U g⁻¹ of substrate. Using these conditions, the results were as follows: the content of cyclodextrins, 50%; the conversion yield of substrate, 25%; the productivity per enzyme unit, 5.22 mg of cyclodextrins.     

Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.

The human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vpr and Vpx proteins are packaged into virions through virus type-specific interactions with the Gag polyprotein precursor. To examine whether HIV-1 Vpr (Vpr1) and HIV-2 Vpx (Vpx2) could be used to target foreign proteins to the HIV particle, their open reading frames were fused in frame with genes encoding the bacterial staphylococcal nuclease (SN), an enzymatically inactive mutant of SN (SN*), and chloramphenicol acetyltransferase (CAT). Transient expression in a T7-based vaccinia virus system demonstrated the synthesis of appropriately sized Vpr1-SN/SN* and Vpx2-SN/SN* fusion proteins which, when coexpressed with their cognate p55Gag protein, were efficiently incorporated into virus-like particles. Packaging of the fusion proteins was dependent on virus type-specific determinants, as previously seen with wild-type Vpr and Vpx proteins. Particle-associated Vpr1-SN and Vpx2-SN fusion proteins were enzymatically active, as determined by in vitro digestion of lambda phage DNA. To determine whether functional Vpr1 and Vpx2 fusion proteins could be targeted to HIV particles, the gene fusions were cloned into an HIV-2 long terminal repeat/Rev response element-regulated expression vector and cotransfected with wild-type HIV-1 and HIV-2 proviruses. Western blot (immunoblot) analysis of sucrose gradient-purified virions revealed that both Vpr1 and Vpx2 fusion proteins were efficiently packaged regardless of whether SN, SN*, or CAT was used as the C-terminal fusion partner. Moreover, the fusion proteins remained enzymatically active and were packaged in the presence of wild-type Vpr and Vpx proteins. Interestingly, virions also contained smaller proteins that reacted with antibodies specific for the accessory proteins as well as SN and CAT fusion partners. Since similar proteins were absent from Gag-derived virus-like particles and from virions propagated in the presence of an HIV protease inhibitor, they must represent cleavage products produced by the viral protease. Taken together, these results demonstrate that Vpr and Vpx can be used to target functional proteins, including potentially deleterious enzymes, to the human or simian immunodeficiency virus particle. These properties may be exploitable for studies of HIV particle assembly and maturation and for the development of novel antiviral strategies.     

Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.

Intracerebral inoculation of susceptible strains of mice with Theiler's murine encephalomyelitis virus (TMEV) results in a chronic, immunologically mediated demyelinating disease that shares many features with human multiple sclerosis. CD4+ T lymphocytes play a critical role in the pathogenesis of virus-induced demyelinating disease. We have identified a region within amino acid residues 24 to 37 of the VP3 capsid protein of TMEV (VP3(24-37)) that is recognized by T lymphocytes from the demyelination-susceptible SJL/J strain of mice. The T-cell response to VP3(24-37) represents a predominant Th-cell response against the virus from either TMEV-immunized or TMEV-infected SJL/J mice, and viral epitopes VP1(233-250), VP2(74-86), and VP3(24-37) account for most of the Th-cell response to TMEV.     

Importance of spore mutants for fed-batch and continuous fermentation of Bacillus subtilis

To alleviate plasmid instability and to prolong the production phase of subtilisin, integrable plasmid and spore mutants are used. Compared with batch-type shake flask cultures, spore mutants' ability to produce subtilisin can be well pronounced in fed-batch and continuous cultures. Hence, the two culture methods make it possible to identify the peculiar characteristics of the spore mutants unobtainable in batch culture. Spore mutants can enhance subtilisin productivity and prolong subtilisin production time in fed-batch culture as well as enable us to use very low dilution rates (<0.1 h(-1)) without losing productivity in continuous culture, thereby improving the conversion yield of the nitrogen source. At 0.05 h(-1) the spollG mutant of Bacillus subtilis DB104 (Deltanpr Deltaapr) (Em(r)) spollG (Bim(r)):: pMK101 (Cm(r)) showed a subtilisin yield about ten times higher than that from wild-type DB104 (Deltanpr Deltaapr)::pMK101 (Cm(r)). (c) 1995 John Wiley & Sons, Inc.